Federation Des Caisses Desjardins Du Quebec Spectrum Pharmaceuticals Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Aug 14, 2024	SELL	$0.0 - $1.03 $0 - $1,648	-1,600 Closed	0 $0
Q1 2022 Aug 14, 2024	BUY	$0.63 - $1.59 $1,008 - $2,544	1,600 New	1,600 $2.06 Million
Q2 2021 Aug 30, 2024	BUY	$2.89 - $4.45 $4,624 - $7,120	1,600 New	1,600 $6 Million
Q4 2018 Aug 30, 2024	BUY	$6.39 - $16.99 $3,195 - $8,495	500 New	500 $4.38 Million
Q2 2018 Aug 30, 2024	SELL	$14.31 - $21.75 $12,277 - $18,661	-858 Reduced 63.18%	500 $10.5 Million
Q4 2017 Aug 30, 2024	SELL	$13.36 - $20.73 $10,688 - $16,584	-800 Reduced 37.07%	1,358 $25.7 Million
Q3 2017 Aug 30, 2024	BUY	$8.75 - $14.07 $18,882 - $30,363	2,158	2,158 $30.4 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account